Trade Summary

3 days ago, Lantheus Holdings, Inc., serving as 10% owner Owner at Perspective Therapeutics, Inc. (CATX), sold 78,145 shares at $3.14 per share, for a total transaction value of $245,609.74. Following this transaction, Lantheus Holdings, Inc. now holds 11,599,194 shares of CATX.

This sale represents a 0.67% decrease in Lantheus Holdings, Inc.'s stake in the company.

The trade was executed on Monday, August 31, 2026 and publicly disclosed via SEC Form 4 filing on Wednesday, September 2, 2026 at 4:36 PM ET, 2 days after the trade was made.

Perspective Therapeutics, Inc. operates in the HEALTHCARE sector, specifically within the MEDICAL DEVICES industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.